Immix Biopharma, Inc.
(NASDAQ: IMMX)
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
5.140
+0.300
(+6.20%)
Range
4.750 - 5.140
(8.21%)
Open
4.930
Previous Close
4.840
Bid Price
1.480
Bid Volume
12
Ask Price
1.500
Ask Volume
10
Volume
165,111
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 23:06.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
